Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

Generated: April 29, 2017

DrugPatentWatch Database Preview

NAPROXEN Drug Profile

« Back to Dashboard

Which patents cover Naproxen, and when can generics launch?

Naproxen is a drug marketed by Teva, Dava Pharms Inc, Invagen Pharms, Teva Pharms, Hamilton Pharms, Ivax Sub Teva Pharms, Roxane, Marksans Pharma, Zydus Pharms Usa, Mylan, Amneal Pharms Ny, Aurobindo Pharma Ltd, Actavis Elizabeth, Pliva, Perrigo R And D, Sandoz, Glenmark Generics, Watson Labs, Purepac Pharm, West-ward Pharms Int, Mylan Pharms Inc, Hikma Intl Pharms, Dr Reddys Labs Ltd, Actavis Labs Fl Inc, Bionpharma Inc, Contract Pharmacal, Able, Granules India, Perrigo, Dr Reddys Labs Inc, Lnk Intl Inc, Hikma, and Sun Pharm Inds Ltd. and is included in sixty-five NDAs.

The generic ingredient in NAPROXEN is naproxen sodium; pseudoephedrine hydrochloride. There are forty-two drug master file entries for this compound. Thirteen suppliers are listed for this compound. Additional details are available on the naproxen sodium; pseudoephedrine hydrochloride profile page.

Summary for Tradename: NAPROXEN

Patents:0
Applicants:33
NDAs:65
Suppliers / Packagers: see list67
Bulk Api Vendors: see list76
Clinical Trials: see list75
Patent Applications: see list7,031
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:NAPROXEN at DailyMed

Pharmacology for Tradename: NAPROXEN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Watson Labs
NAPROXEN
naproxen
TABLET;ORAL074163-002Feb 10, 1995DISCNNoNo► Subscribe► Subscribe
Contract Pharmacal
NAPROXEN SODIUM
naproxen sodium
TABLET;ORAL074635-001Jan 13, 1997OTCNoNo► Subscribe► Subscribe
Amneal Pharms Ny
NAPROXEN
naproxen
TABLET;ORAL075927-003Dec 18, 2001ABRXNoNo► Subscribe► Subscribe
Zydus Pharms Usa
NAPROXEN
naproxen
TABLET;ORAL078620-002Jun 7, 2007ABRXNoNo► Subscribe► Subscribe
Hamilton Pharms
NAPROXEN SODIUM
naproxen sodium
TABLET;ORAL074106-002Aug 31, 1993DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Predict branded drug patent expiration
  • Drug patents and clinical trials in dozens of countries
  • Set up watchlists for daily email updates

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot